Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

International Pricing Index Could Suffer From Industry Gaming

Oct 08 2019

• By Michael Cipriano

Scott Gottlieb — Former FDA Commissioner is skeptical about the IPI.

Related Content

Gottlieb Tells Brand Firms To Sell Samples For Generics – Or Face The Consequences

Jul 30 2019

Florida’s Importation Plan: 45% Markup On Canadian Prices Expected To Cover Costs And Produce Savings

Aug 30 2019

REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'

May 18 2018

US FDA Changing View Of Citizen Petition Response Time, Could Eliminate Serial Refiling

Oct 03 2018

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

What’s Next For The International Pricing Index? Parsing A Strange US Senate Vote

Jul 29 2019

Related Companies

Pfizer Inc.

Additional Topics

United States Pricing Debate Reimbursement Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window